By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bioaxone Biosciences 

Cambridge  Massachusetts    U.S.A.
Phone: n/a Fax: n/a



Company News
Bioaxone Biosciences CEO Lisa McKerracher Accepts Role Of Consortium Advisory Panelist For The Christopher Reeve Foundation 8/10/2017 12:26:50 PM
Bioaxone Biosciences Announces Peer-Reviewed Research Article On Axon Regeneration Published In Frontiers Journal Series 7/19/2017 7:58:40 AM
Bioaxone Biosciences Announces New Hires To Support Investigational New Drug Filing 5/11/2017 8:21:07 AM
Bioaxone Biosciences Continues Plans For Growth With Manufacturing Contract 5/2/2017 7:46:07 AM
Bioaxone Biosciences Appoints Dr. Catherine Sohn To Lead Corporate Development 4/21/2017 6:38:05 AM
Bioaxone Biosciences Announces NIH/SBIR Fast Track Grant To Develop BA-1049 For Treatment Of Cerebral Cavernous Malformation/Angioma 2/8/2016 12:24:20 PM
Bioaxone Biosciences Announces Publication of Cethrin™ Spinal Cord Injury Clinical Trial Analysis of Treatment Outcomes in the Journal of Neurotrauma 9/25/2013 11:20:18 AM
Nordion International and Bioaxone Biosciences Reach an Agreement to Settle Claims 9/24/2013 10:03:20 AM
Bioaxone Biosciences Celebrates Official Opening of Clinical and Research Operations in Cambridge, Mass. 11/28/2012 2:22:33 PM